Publications
Preprints and pre-reviewed scientific papers about SARS-COV-2 seroprevalence studies.
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
The serologic response of individuals with mild forms of SARS-CoV-2 infection is poorly characterized.
Early antibody response to SARS-CoV-2
The role and significance of the immune response to SARS-CoV-2 infection is not yet well known.
Early experiences with antibody testing in a Flemish nursing home during an acute COVID-19 outbreak: a retrospective cohort study.
To assess the prevalence of COVID-19 (PCR-test) in residents and staff of a nursing home.
Susceptibility-adjusted herd immunity threshold model and potential R0 distribution fitting the observed Covid-19 data in Stockholm
The reproduction number, R0, is commonly used, and sometimes misused, in conjunction with the classic Kermack and McKindrick theory based on the assumption of homogeneity, in order to estimate herd immunity threshold (HIT).
Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
Covid-19 pandemic by the new coronavirus SARS-Cov-2 has produced
devastating effects on the health care system, affecting also cancer patient care.
Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience
Determine the percentage of healthcare workers (HCW) carrying SARS-CoV-2 in high exposure areas of the hospital.
Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff
The aim of this study was to test Rutherford Health (RH) staff for the presence of SARS CoV-2 antibodies to reduce the risk of infection to cancer patients.
SARS-CoV-2 seroconversion in health care workers
The correlates of protection against SARS-CoV-2 and their longevity remain unclear.
Experience of quantitative SARS-CoV-2 antibody screening of health-care workers in the southern part of Kyoto city during COVID-19 peri-pandemic period
The coronavirus disease-2019 (COVID-19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity.
SARS-CoV-2 Antibody responses do not predict COVID-19 disease severity
Initial reports indicate adequate performance of some serological-based SARS-CoV-2 assays.
Perceived versus proven SARS-CoV-2 specific immune responses in health care workers
Uncertain rates of asymptomatic infections have raised concerns about potentially high rates of thus far undiagnosed SARS-CoV-2 infections.
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
The Milan metropolitan area in Northern Italy was among the most severely hit by the SARS-CoV-2 outbreak.